Instylla is a privately held company focused on developing peripheral liquid embolic products based on its proprietary hydrogel technology to improve patient outcomes, procedure efficiency, and enable new therapies.
Market
Healthcare
Location
Bedford,
MA,
USA
Coinvestors
BAMED Ventures, Ascension Ventures, Catalyst Health Ventures, Excelestar Ventures, Sparta Group